WO2002042490A1 - Method of optimising the sequences of synthetic nucleic acids - Google Patents

Method of optimising the sequences of synthetic nucleic acids Download PDF

Info

Publication number
WO2002042490A1
WO2002042490A1 PCT/EE2000/000003 EE0000003W WO0242490A1 WO 2002042490 A1 WO2002042490 A1 WO 2002042490A1 EE 0000003 W EE0000003 W EE 0000003W WO 0242490 A1 WO0242490 A1 WO 0242490A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleotides
probe
oligonucleotides
target
hybridization
Prior art date
Application number
PCT/EE2000/000003
Other languages
French (fr)
Inventor
Hendrik Pavel
Neeme TÕNISSON
Jana Zernant
Original Assignee
Asper OÜ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asper OÜ filed Critical Asper OÜ
Priority to PCT/EE2000/000003 priority Critical patent/WO2002042490A1/en
Priority to AU2001216942A priority patent/AU2001216942A1/en
Publication of WO2002042490A1 publication Critical patent/WO2002042490A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6832Enhancement of hybridisation reaction

Definitions

  • the present invention falls in the fields of molecular biology and molecular diagnostics. More specifically it concerns a method of optimizing the sequences of synthetic nucleic acids, used in methods based on hybridization of target DNA (DNA chips etc). The optimization involves swapping natural nucleotides for modified ones.
  • oligonucleotide primers are bound to a solid support in a two- dimensional array, each primer for identifying one base in the examined sequence.
  • the array may be designed in a manner where consecutive primers correspond to consecutive nucleotides in the target nucleic acid.
  • the primers may correspond to nucleotides in various (parts of) genes or nucleotides scattered over the whole genome.
  • the target nucleic acid is added on the array under hybridizing conditions together with the enzyme DNA polymerase and labelled terminator nucleotides.
  • the hybridization of the target with the complementary primer will be followed by the incorporation by the polymerase of one labelled nucleotide in the end of the primer, which is complementary to the first overextending nucleotide of the target.
  • a dideoxynucleotide becomes incorporated, however, different methods may use deoxynucleotides or oligonucleotides for the elongation.
  • This enzymatic reaction will be followed by rinsing away everything that is not covalently bound to the support.
  • the label- carrying primers remain on the support.
  • the different characteristics of the labels refer to different nucleotides. Thus the presence or absence of a nucleotide in a certain position in the target sequence will be validated.
  • oligonucleotide primers covalently bound to the support, may under hybridizing conditions hybridize between themselves. Theoretically, the formation of both "hairpin” structures and dimers or “bridges” is allowed, see Fig. 1. The change in the free energy of the latter is essentially larger, so in practice those should be considered. The formation of dimers will decrease the number of primer-target hybridization events. Thus the quantity of the incorporated labelled nucleotide may remain under detectable level.
  • Another problem is self-elongation, if the hybridization along the two primer molecules reaches their 3' ends. In the present system the primers are bound to the support by the 5' end and the 3' end is in the solution.
  • the 3' end is involved in a dimer, it will be a target for the polymerase, which will incorporate a labelled nucleotide in its end. Usually the latter is not the same, what would be expected from the reaction involving both primer and target (Fig. lb). Thus false positive and false negative results will be obtained.
  • the present invention provides a method, where the oligonucleotide primers are modified. This is done during the synthesis of the primers. Modified or universal nucleotides are incorporated in the primers. This has to be done in a way that will prevent the formation of the predicted dimers or, if they do form, to prevent the incorporation of nucleotides due to self-priming (see Fig. 1). At the same time, the specific hybridization with the target must not be lost. Such a situation is obtainable if the nucleotides, participating in secondary structures, can be predicted.
  • the hybridization between oligonucleotides can be predicted using widespread software, written for polymerase chain reaction (PCR) primer synthesis.
  • the dimers can be formed if some fragment within the primer is complementary to its own mirror image. Such fragments may occur as various strings and in various positions. Usually these fragments contain dA and dT. Their positions can easily be determined (see Fig. 1).
  • the hybridization in the forming dimers will be essentially weaker.
  • the primer-target hybridization will not be impaired; in the present situation it will be stronger instead.
  • the hybridization is carried out on a solid carrier.
  • primer-target hybridization may also be carried out in a solution or in a gel.
  • Fig. la depicts the formation of dimers between oligonucleotides and how the modified nucleotides disrupt the dimers, due to a smaller number of hydrogen bonds.
  • 12088s and 14040s are oligonucleotides' designations.
  • FIG. 2 depicts images of APEX reaction results on an array
  • the experiments have been made with the same sa'mple of DNA but at varying temperatures (upper and lower pane)
  • the oligonucleotides 12088s and 14040s serve as probes that hybridize to target DNA fragments
  • a fluorescently marked A, C or G dideoxynucleotide becomes incorporated by the polymerase
  • the T image is not shown as no signals were detected there
  • the markers are self-elongating oligonucleotides giving signals in both A, C and G channels
  • X 2- amino-A
  • Y 2-thio-T
  • 12088s that should give a C signal does not readily do so at 58°C. This must be due to the secondary structures between the oligonucleotide itself, which does not allow for the hybridization and elongation. 12088sXXYY gives a visible signal of C and 12088sXY the strongest one. All the oligonucleotides give some dimer structure followed by the self- extensive incorporation of A, but the latter is weak in comparison to the signal from the oligonucleotide-target DNA hybridization.
  • the XY modification gives a clearly stronger signal of oligonucleotide-target DNA hybridization over the unmodified 14040s (channel G).

Abstract

The invention tackles the problem of oligonucleotides forming complexes between or within themselves. Firstly, the sequences of oligonucleotides are tested for potential secondary structures. Then, when designing the sequences of the oligonucleotides, the nucleotides responsible for forming hydrogen bonds in the secondary structures, are swapped. They are replaced by universal or specifically binding nucleotides. In the current proof of principle, pairs of 2-amino-dA and 2-thio-dT are used to demonstrate that the balance between probe-probe and probe-target hybridization becomes shifted in the more favoured direction. This results in stronger signals and lesser false signals.

Description

Method of optimising the sequences of synthetic nucleic acids
THE TECHNICAL FIELD
The present invention falls in the fields of molecular biology and molecular diagnostics. More specifically it concerns a method of optimizing the sequences of synthetic nucleic acids, used in methods based on hybridization of target DNA (DNA chips etc). The optimization involves swapping natural nucleotides for modified ones.
BACKGROUND OF THE INVENTION
One application of the method in the present invention, (included in the description of the subject matter of the invention) is nucleic acid sequence analysis on solid support, for reference, see patent EP 0705349 "Parallel Extension Approach to Nucleic Acid Sequence Analysis."
In the said method, oligonucleotide primers are bound to a solid support in a two- dimensional array, each primer for identifying one base in the examined sequence. The array may be designed in a manner where consecutive primers correspond to consecutive nucleotides in the target nucleic acid. Also, the primers may correspond to nucleotides in various (parts of) genes or nucleotides scattered over the whole genome. The target nucleic acid is added on the array under hybridizing conditions together with the enzyme DNA polymerase and labelled terminator nucleotides. The hybridization of the target with the complementary primer will be followed by the incorporation by the polymerase of one labelled nucleotide in the end of the primer, which is complementary to the first overextending nucleotide of the target. In the experiment demonstrated in the proof of principle, a dideoxynucleotide becomes incorporated, however, different methods may use deoxynucleotides or oligonucleotides for the elongation. This enzymatic reaction will be followed by rinsing away everything that is not covalently bound to the support. The label- carrying primers remain on the support. The different characteristics of the labels refer to different nucleotides. Thus the presence or absence of a nucleotide in a certain position in the target sequence will be validated. The problem with the said method is that the oligonucleotide primers, covalently bound to the support, may under hybridizing conditions hybridize between themselves. Theoretically, the formation of both "hairpin" structures and dimers or "bridges" is allowed, see Fig. 1. The change in the free energy of the latter is essentially larger, so in practice those should be considered. The formation of dimers will decrease the number of primer-target hybridization events. Thus the quantity of the incorporated labelled nucleotide may remain under detectable level. Another problem is self-elongation, if the hybridization along the two primer molecules reaches their 3' ends. In the present system the primers are bound to the support by the 5' end and the 3' end is in the solution. If the 3' end is involved in a dimer, it will be a target for the polymerase, which will incorporate a labelled nucleotide in its end. Usually the latter is not the same, what would be expected from the reaction involving both primer and target (Fig. lb). Thus false positive and false negative results will be obtained.
SUBJECT MATTER OF THE INVENTION
As a solution to the problems mentioned above and also as an improvement of other methods, comprising hybridization of synthetic oligonucleotides, the present invention provides a method, where the oligonucleotide primers are modified. This is done during the synthesis of the primers. Modified or universal nucleotides are incorporated in the primers. This has to be done in a way that will prevent the formation of the predicted dimers or, if they do form, to prevent the incorporation of nucleotides due to self-priming (see Fig. 1). At the same time, the specific hybridization with the target must not be lost. Such a situation is obtainable if the nucleotides, participating in secondary structures, can be predicted. During the synthesis, in these positions, universal nucleotides, e.g. inosin, or specifically binding nucleotides, will be incorporated. The latter are ho ologues of natural nucleotides. The specifically binding nucleotides are described in the patent US 512340. In the present invention, in the proof of principle, 2-amino-dA and 2-thio-dT are used in pairs. Those two nucleotides bind to their natural counterpart a little stronger than the natural dA and dT. At the same time, 2-amino-dA and 2-thio-dT bond between themselves significantly weaker than natural dA and dT. This is because only one hydrogen bond forms instead of two. The same goes for the modified dG and dC, which give weak bonding between these two, but strong with natural dG or dC nucleotide. The described feature has been taken advantage of in the proof of principle. Modified nucleotides have been incorporated in the oligonucleotides to be hybridized with the target. In conclusion the specificity and credibility of the reaction results are improved.
THE PROOF OF PRINCIPLE
The hybridization between oligonucleotides (the formation of dimers) can be predicted using widespread software, written for polymerase chain reaction (PCR) primer synthesis. The dimers can be formed if some fragment within the primer is complementary to its own mirror image. Such fragments may occur as various strings and in various positions. Mostly these fragments contain dA and dT. Their positions can easily be determined (see Fig. 1).
If now, in the primer, one swaps dA and dT for 2-amino-dA and 2-thio-dT modified nucleotides, the hybridization in the forming dimers will be essentially weaker. At the same time, the primer-target hybridization will not be impaired; in the present situation it will be stronger instead. In the example drawn hereunder, the hybridization is carried out on a solid carrier. In addition to this condition, primer-target hybridization may also be carried out in a solution or in a gel.
Thus the balance of hybridization is shifted from primer-primer to primer-target. There will be more labels incorporated during primer-target hybridization and less false signals from primer-primer hybridization. The results of the experiment providing the proof of principle are shown on Figure 2.
BRIEF DESCRIPTION OF THE DRAWINGS
Hereunder the invention is described with the help of figures, where:
Fig. la depicts the formation of dimers between oligonucleotides and how the modified nucleotides disrupt the dimers, due to a smaller number of hydrogen bonds. 12088s and 14040s are oligonucleotides' designations. The 12088s hairpin structure:
5' CCGGACGATATTGAACAA IIIII ) 3' ACTTGGT
12088s dimer:
5' CCGGACGATATTGAACAATGGTTCA 3' IIIII-II-IIIII 3' ACTTGGTAACAAGTTATAGCAGGCC 5'
12088sXY:
5' CCGGACGATATTGXACAATGGTYCA 3' II-II-II-II-II 3' ACYTGGTAACAXGTTATAGCAGGCC 5'
12088sXXYY:
5' CCGGACGATATTGXXCAATGGYYCA 3' II--I-II-I — II 3' ACYYGGTAACXXGTTATAGCAGGCC 5' ,
where X = 2-amino-A and Y = 2-thio-T
14040s dimer: 5' ACCACCATCCACTACAACTACATGT 3'
3' TGTACATCAACATCACCTACCACCA 5'
14040sXY: 5' ACCACCATCCACTACAACTACXYGT 3'
II — II 3' TGYXCATCAACATCACCTACCACCA 5' "I" designates complementarity between the nucleotides
Figure lb Incorporating a false signal into the oligonucleotide during self-extension If the reaction conditions favour the formation of the said dimers of 12088s and 14040s, they will also give self-extension This means that in the present case the polymerase would add to the 3' ends of both 12088s and 14040s an A nucleotide, according to complementarity with the successive T
To the 3' end of the 12088s dimer an A (marked A*) will be added, in a complementary manner A is not the same as would be incorporated following oligonucleotide-target hybridization (C)
CCGGACGATATTGAACAATGGTTCAA* 3 ' I I I I I-II-II I I I 3 ' ACTTGGTAACAAGTTATAGCAGGCC 5'
To the dimer of 14040s an A is added by the complementarity principle (marked A*), which is not the expected signal (G) from the DNA target
5' ACCACCATCCACTACAACTACATGTA* 3 '
Him
3' TGTACATCAACATCACCTACCACCA 5'
"I" designates complementarity between the nucleotides
Hereunder, the APEX reaction results are depicted when carried out at 50°C The T channel was left out as no signals were detected
Figure imgf000006_0001
The figure demonstrates that under these conditions, self-extension may be comparable or even stronger than the expected signal
Figure 2 depicts images of APEX reaction results on an array The experiments have been made with the same sa'mple of DNA but at varying temperatures (upper and lower pane) The oligonucleotides 12088s and 14040s serve as probes that hybridize to target DNA fragments A fluorescently marked A, C or G dideoxynucleotide becomes incorporated by the polymerase The T image is not shown as no signals were detected there The markers are self-elongating oligonucleotides giving signals in both A, C and G channels X = 2- amino-A, Y = 2-thio-T
Figure imgf000007_0001
The two panes for different temperatures look essentially the same
The superiority of the oligonucleotides carrying modified bases can be seen from the following
12088s that should give a C signal does not readily do so at 58°C. This must be due to the secondary structures between the oligonucleotide itself, which does not allow for the hybridization and elongation. 12088sXXYY gives a visible signal of C and 12088sXY the strongest one. All the oligonucleotides give some dimer structure followed by the self- extensive incorporation of A, but the latter is weak in comparison to the signal from the oligonucleotide-target DNA hybridization.
In the case of 14040s, the XY modification gives a clearly stronger signal of oligonucleotide-target DNA hybridization over the unmodified 14040s (channel G).

Claims

Claims
1. A method of modifying oligonucleotides, used in nucleotide sequence analysis with the primer extension or any other method or used in any other molecular method, comprising a step of probe-target nucleic acid hybridization, wherein the step of probe-target nucleic acid hybridization may be carried out in either solution, gel or on a solid carrier.
2. A method according to the claim 1, comprising a step of the enzymatic elongation of the probe with the marked or non marked nucleotides, wherein it may be carried out in either solution, gel or on a solid carrier.
3. A method according to the claim 2, characterized in that the fluorescently marked nucleotides are used for the enzymatic elongation of the probe.
4. A method according to the claim 3, characterized in that the nucleotides used for the enzymatic elongation are deoxynucleotides, dideoxy nucleotides or oligonucleotides.
5. A method according to the claims 2 to 4, characterized in that the enzymatic elongation of the probe occurs complementary with the target nucleotide acid.
6. A method according to the claim 1, characterized in that the sequence of the oligonucleotides with the known sequence is such that they may form secondary structures between or within the identical molecules, impairing their ability to hybridize with the target nucleotide acid.
7. A method according any of the preceding claims, characterized in that the secondary structures may be predicted from the sequence of the nucleotides used as target.
8. A method according to the claims 1 to 7, characterized in that the probes of the oligonucleotides are synthesized in such a manner that the pairs of nucleotides predicted to participate in secondary structures are swapped for pairs of modified nucleotides, comprising either universal bases or homologues of the natural bases.
9. A method according to the claim 8, characterized in that the modifications being such that they substantially weaken the bond between the complementary pair of modified (universal) nucleotides in the secondary structure, but do not significantly weaken the bond between the modified nucleotides and their complementary nucleotides in the target nucleotide acid, thus shifting the direction of hybridization from probe-probe to probe- target nucleotide acid.
10. A method according to any of the claims 1 to 9, characterized in that the analyzed positions may be dispersed over the gene, genes or genome.
11. A method according to any of the preceding claims, characterized in that the analyzed position may be consecutive.
PCT/EE2000/000003 2000-11-24 2000-11-24 Method of optimising the sequences of synthetic nucleic acids WO2002042490A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/EE2000/000003 WO2002042490A1 (en) 2000-11-24 2000-11-24 Method of optimising the sequences of synthetic nucleic acids
AU2001216942A AU2001216942A1 (en) 2000-11-24 2000-11-24 Method of optimising the sequences of synthetic nucleic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EE2000/000003 WO2002042490A1 (en) 2000-11-24 2000-11-24 Method of optimising the sequences of synthetic nucleic acids

Publications (1)

Publication Number Publication Date
WO2002042490A1 true WO2002042490A1 (en) 2002-05-30

Family

ID=8161604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EE2000/000003 WO2002042490A1 (en) 2000-11-24 2000-11-24 Method of optimising the sequences of synthetic nucleic acids

Country Status (2)

Country Link
AU (1) AU2001216942A1 (en)
WO (1) WO2002042490A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104093850A (en) * 2012-02-15 2014-10-08 通用电气公司 Methods and kits for reducing non-specific nucleic acid amplification

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000669A1 (en) * 1993-06-22 1995-01-05 Pharmacia Biotech Ab Parallel primer extension approach to nucleic acid sequence analysis
WO2000020630A1 (en) * 1998-10-07 2000-04-13 Mcgill University Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000669A1 (en) * 1993-06-22 1995-01-05 Pharmacia Biotech Ab Parallel primer extension approach to nucleic acid sequence analysis
WO2000020630A1 (en) * 1998-10-07 2000-04-13 Mcgill University Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HARTEMINK A J ET AL.: "Automated constraint-based nucleotide sequence selection for DNA computation", BIOSYSTEMS, vol. 52, October 1999 (1999-10-01), pages 227 - 235, XP001023814 *
SANGER F ET AL: "DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, NEW YORK, NY, US, vol. 74, no. 12, 1 December 1977 (1977-12-01), pages 5463 - 5467, XP000603873 *
SASAKI N ET AL: "Identification of stable RNA hairpins causing band compression in transcriptional sequencing and their elimination by use of inosine triphosphate", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 222, no. 1, 5 November 1998 (1998-11-05), pages 17 - 24, XP004151160, ISSN: 0378-1119 *
SHAPIRO B A ET AL: "OPTIMIZATION AND PERFORMANCE ANALYSIS OF A MASSIVELY PARALLEL DYNAMIC PROGRAMMING ALGORITHM FOR RNA SECONDARY STRUCTURE PREDICTION", 3HE INTERNATIONAL JOURNAL OF SUPERCOMPUTER APPLICATIONS AND HIGH PERFORMANCE COMPUTING, MIT PRESS, US, vol. 9, no. 1, 21 March 1995 (1995-03-21), pages 29 - 39, XP000502546, ISSN: 1078-3482 *
TYAGI S ET AL: "MOLECULAR BEACONS: PROBES THAT FLUORESCE UPON HYBRIDIZATION", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 14, 1 March 1996 (1996-03-01), pages 303 - 308, XP000196024, ISSN: 1087-0156 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104093850A (en) * 2012-02-15 2014-10-08 通用电气公司 Methods and kits for reducing non-specific nucleic acid amplification
JP2015507930A (en) * 2012-02-15 2015-03-16 ゼネラル・エレクトリック・カンパニイ Method and kit for reducing non-specific nucleic acid amplification
EP2814976A4 (en) * 2012-02-15 2015-09-09 Gen Electric Methods and kits for reducing non-specific nucleic acid amplification
US9353393B2 (en) 2012-02-15 2016-05-31 General Electric Company Methods and kits for reducing non-specific nucleic acid amplification
CN104093850B (en) * 2012-02-15 2016-12-07 通用电气公司 For reducing method and the test kit of non-specific nucleic acid amplification

Also Published As

Publication number Publication date
AU2001216942A1 (en) 2002-06-03

Similar Documents

Publication Publication Date Title
CA2239287C (en) A cascade nucleic acid amplification reaction
US6268147B1 (en) Nucleic acid analysis using sequence-targeted tandem hybridization
EP0676476B1 (en) Isothermal strand displacement nucleic acid amplification
US7230092B2 (en) Capture moieties for nucleic acids and uses thereof
US20210230670A1 (en) Solid phase nucleic acid target capture and replication using strand displacing polymerases
AU3586693A (en) Method for use of branched nucleic acid probes
CA2368169A1 (en) Detection of mutations in genes by specific lna primers
WO2000026412A1 (en) Nucleic acid analysis using sequence-targeted tandem hybridization
IL152727A (en) Single copy genomic hybridization probes and method of generating same
AU2001264610B2 (en) Single copy genomic hybridization probes and method of generating same
WO2001079563A2 (en) Degradable nucleic acid probes and nucleic acid detection methods
EP1169474A1 (en) Olignucleotide array and methods of use
US6787310B2 (en) Strand displacement methods employing competitor oligonucleotides for isolating one strand of a double-stranded nucleic acid
JP3923917B2 (en) Target production method, target sequence detection method, target and target sequence detection assay kit
US20030180776A1 (en) Detection by sliding template amplification
WO2002042490A1 (en) Method of optimising the sequences of synthetic nucleic acids
EP4012029A1 (en) Method for capturing nucleic acid molecule, preparation method for nucleic acid library, and a sequencing method
US20230242971A1 (en) Removal of excess oligonucleotides from a reation mixture
EP1370687A1 (en) DETECTING BINDING OF mRNA TO AN OLIGONUCLEOTIDE ARRAY USING RNA DEPENDENT NUCLEIC ACID MODIFYING ENZYMES
WO2002024960A1 (en) Detection of dna variation
AU2001259096A1 (en) Degradable nucleic acid probes and nucleic acid detection methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase